Cancer, Costs and Compulsion: Kerala High Court Opens the Section 100 Patents Act Door
In In Re Exorbitant Pricing of Life Saving Patented Medicines, the Kerala High Court asked whether the Section 100 Patents Act lets the Union of India make and…
Novartis
13 articles
Quia Timet Patent Injunction Stops Intas’s Dabrafenib Launch
Novartis AG sought a quia timet patent injunction against Intas Pharmaceuticals Limited before the Delhi High Court, alleging that regulatory filings and an investigation report revealed imminent infringement…
Bolar Is Not a Blanket: Madras High Court on Vildagliptin API Exports
In the case of Novartis AG v. Venkata Narayana Active Ingredients Pvt. Ltd., the Madras High Court dealt with a familiar pharmaceutical patent question in a concrete factual…
Strategic Delay Costs Novartis Its Cross-Examination Rights
The Delhi High Court dismissed Novartis’s writ petitions, ruling it had waived cross-examination by opting for rebuttal evidence. The Controller’s orders were upheld, with the patent already revoked…
Revisiting Novartis versus Natco – Cancer drugs, divisional applications and patent validity
The Delhi High Court upheld the validity of Novartis’s Ceritinib patent against Natco’s challenge, addressing divisional application issues and allegations of suppression. The injunction against Natco remains in…
Novartis says No to Novarish
The Bombay High Court granted Novartis an injunction against Novarish Healthcare for trademark infringement and passing off. The court found the marks deceptively similar and protected Novartis's established…
Cancerous Battle: Novartis and NATCO clash over Eltrombopag
The Delhi High Court Division Bench set aside an injunction against Natco Pharma in the Novartis Eltrombopag patent dispute. The judgment provides key guidance on patent validity challenges…
Profiting from the Patent Cliff: What Drug Manufacturers Need to Know about Secondary Patents
This post explores how drug manufacturers leverage secondary patents to manage the patent cliff and maintain exclusivity. A detailed analysis of Entresto’s patent timeline and Indian legal context…
Latest Patent & Design Updates – January 2022 – Part 1
The post analyses significant patent and design updates for January 2022, focusing on India’s WTO patent waiver request and RGNIIPM’s training initiative. It also highlights major international patent…
Latest Patent Cases in 2021 – Part 3
This article examines recent patent litigation before the Delhi High Court, highlighting cases involving Novartis and Sulphur Mills in 2021. It discusses key judicial findings on patent validity,…